Evidence mapPaperPMID 41999637Full record

ReviewESC heart failure2026

Worsening heart failure-based hierarchical endpoints beyond HF hospitalization: expert opinion paper.

Agustín Fernández-Cisnal, Gema Miñana, Rafael de la Espriella, Enrique Santas, Joan Carles Trullas, Jan Biegus, Harriette Van Spall, Julio Núñez

Abstract readReview
In one paragraph

Review in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agustín Fernández-CisnalCardiology Department, Parc Sanitari Sant Joan de Deu, Hospital Sant Boi, Sant Boi de Llobregat, Barcelona, Spain.ORCID 0000-0002-0672-0696
Gema MiñanaCardiology Department, Hospital Clínico Universitario de València, Instituto de Investigación Sanitaria (INCLIVA), University of Valencia, Avenida Blasco Ibáñez 17, València 46010, Spain.
Rafael de la EspriellaCardiology Department, Hospital Clínico Universitario de València, Instituto de Investigación Sanitaria (INCLIVA), University of Valencia, Avenida Blasco Ibáñez 17, València 46010, Spain.ORCID 0000-0002-8720-3999
Enrique SantasCardiology Department, Hospital Clínico Universitario de València, Instituto de Investigación Sanitaria (INCLIVA), University of Valencia, Avenida Blasco Ibáñez 17, València 46010, Spain.
Joan Carles TrullasInternal Medicine Department, Hospital d'Olot i comarcal de la Garrotxa, Girona, Spain.
Jan BiegusDepartment of Cardiology, Clinical Department of Intensive Cardiac Care, Faculty of Medicine, Wroclaw Medical University, Institute of Heart Diseases, Borowska 213, Wroclaw 50-556, Poland.ORCID 0000-0001-9977-7722
Harriette Van SpallDepartment of Medicine, Faculty of Health Sciences, McMaster University, Population Health Research Institute, Hamilton, Canada.
Julio NúñezCardiology Department, Hospital Clínico Universitario de València, Instituto de Investigación Sanitaria (INCLIVA), University of Valencia, Avenida Blasco Ibáñez 17, València 46010, Spain.ORCID 0000-0003-1672-7119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The traditional, hospitalization-centric composite endpoint of cardiovascular (CV) death or time-to-first heart failure (HF) hospitalization is increasingly misaligned with contemporary HF care and, as evidence-based therapies lower event rates over time, requires larger trials with longer follow-up. Improved survival, modern ambulatory pathways mean that a larger share of worsening HF is treated outside the hospital and that patients may experience recurrent worsening HF episodes. Relying on time-to-first hospitalization alone can therefore miss clinically relevant morbidity; recurrent-event approaches can offer additional power mainly when risk heterogeneity is high and treatment discontinuation after a first event is infrequent. To address this gap, we propose a standardized, adjudicated definition of worsening HF events informed by published consensus definitions, expanded to capture ambulatory events across care settings. Building on this definition, we recommend hierarchical primary endpoints that prioritize all-cause death with CV death evaluated as a secondary mortality outcome when prespecified and adjudicated, while robustly measuring morbidity through total adjudicated worsening HF events (first and recurrent), with validated patient-reported outcomes as additional hierarchical levels. We outline operational considerations for event capture and adjudication, including prioritized composite analytic approaches, and highlight safeguards to mitigate ascertainment bias and dilution by more subjectively defined events. Adoption of worsening HF -based hierarchical endpoints can better reflect the total disease burden, improve statistical power, and enhance interpretability across evolving care models.

Indexed as

Endpoint DeterminationHeart FailureHospitalizationDisease ProgressionHumansPrognosisClinical trial endpointsHierarchical compositeTotal eventsWorsening heart failure

Identifiers

PMID41999637
PMCPMC13122628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.